Back to modules
Module 02  ·  Coming Soon

PatNav — Patient
Navigation Suite

Map every patient touchpoint from prescription to long-term adherence. Identify prior authorisation barriers, co-pay friction, and drop-off points that erode therapy uptake and revenue.

360°
Patient journey visibility
50+
Therapeutic areas covered
30%
Average adherence uplift
Real-time
Barrier identification
The Reality

The access gap patients and your P&L both pay for

Adherence failure is not a patient problem. It is an access intelligence problem.

50%
Of patients with chronic conditions discontinue therapy within 12 months — invisible to most launch revenue models.
$500B+
Annual global cost of medication non-adherence, driven by access friction and co-pay burden.
30%
Improvement in persistence when prior-authorisation barriers are systematically identified and addressed.
Greater dropout risk for patients facing out-of-pocket costs above $100/month vs co-pay-assisted peers.
Capabilities

From prescription to adherence

PatNav visualises the full patient journey, revealing where access breaks down and where intervention has the greatest commercial and clinical impact.

Journey Mapping
Patient Journey Visualisation

Map every touchpoint from initial diagnosis to sustained adherence. Identify where patients disengage, delay, or abandon therapy — and quantify the revenue impact at each stage.

Access Barriers
Prior Authorisation Tracking

Monitor prior authorisation requirements across payers and therapeutic areas. Surface approval rates, turnaround times, and denial patterns to inform field force and hub strategies.

Financial Barriers
Co-pay & Out-of-Pocket Analysis

Quantify co-pay burden and out-of-pocket exposure by payer, geography, and patient segment. Model the uptake elasticity of co-pay assistance programmes before committing budget.

Adherence Intelligence
Persistence & Dropout Modelling

Predict adherence curves and dropout probability by therapy stage. Identify the highest-leverage intervention windows to extend persistence and protect peak-sales projections.

The Strategic Imperative

Why PatNav exists

50%
Of patients with chronic conditions abandon therapy within the first year — invisible to most launch models
30%
Average improvement in therapy persistence when prior-auth friction is identified and addressed systematically
$500B+
Annual global cost of medication non-adherence — a market failure that PatNav is built to reverse
Get Started

Request access to PatNav

Be among the first to map patient journeys with the precision your access teams need. Early access cohort forming now.

Request Early Access